المؤلفون: Mason, MD, Moore, R, Jones, G, Lewis, G, Donovan, JL, Neal, DE, Hamdy, FC, Lane, JA, Staffurth, JN

المصدر: Clinical oncology (Royal College of Radiologists (Great Britain)). 28(9):E92-E100

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:134051241

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Turnham DJ; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Mullen MS; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Bullock NP; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Gilroy KL; Cancer Research UK Scotland Institute, Glasgow G61 1BD, UK., Richards AE; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Patel R; Division of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Quintela M; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Meniel VS; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Seaton G; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Kynaston H; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK.; Department of Urology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff CF14 4XW, UK., Clarkson RWE; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Phesse TJ; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK.; The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC 3000, Australia., Nelson PS; Division of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.; Department of Urology, University of Washington, Seattle, WA 98195, USA.; Department of Medicine, University of Washington, Seattle, WA 98195, USA., Haffner MC; Division of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Staffurth JN; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff CF14 4XN, UK., Pearson HB; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK.

المصدر: Cells [Cells] 2024 Apr 12; Vol. 13 (8). Date of Electronic Publication: 2024 Apr 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant*/pathology , Prostatic Neoplasms, Castration-Resistant*/genetics , Prostatic Neoplasms, Castration-Resistant*/metabolism , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Receptors, Androgen*/metabolism , Receptors, Androgen*/genetics , Piperazines*, Male ; Humans ; Animals ; Mice ; Xenograft Model Antitumor Assays ; Phenylthiohydantoin/pharmacology ; Phenylthiohydantoin/analogs & derivatives ; Phenylthiohydantoin/therapeutic use ; Neoplasm Metastasis ; Nitriles/pharmacology ; Disease Models, Animal ; Benzamides/pharmacology ; Phthalazines/pharmacology ; Phthalazines/therapeutic use

المؤلفون: Staffurth JN; Cardiff University/Velindre Cancer Centre, Cardiff, UK., Haviland JS; The Institute of Cancer Research, London, UK. Electronic address: jo.haviland@icr.ac.uk., Wilkins A; The Institute of Cancer Research, London, UK., Syndikus I; Clatterbridge Cancer Centre, Wirral, UK., Khoo V; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Bloomfield D; Brighton and Sussex University Hospitals, Brighton, UK., Parker C; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Logue J; Christie Hospital, Manchester, UK., Scrase C; Ipswich Hospital, Ipswich, UK., Birtle A; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK., Malik Z; Clatterbridge Cancer Centre, Wirral, UK., Panades M; Lincoln County Hospital, Lincoln, UK., Eswar C; Clatterbridge Cancer Centre, Wirral, UK., Graham J; Beacon Centre, Musgrove Park Hospital, Taunton, UK., Russell M; Beatson West of Scotland Cancer Centre, Glasgow, UK., Ferguson C; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK., O'Sullivan JM; Queen's University Belfast, Belfast, UK., Cruickshank CA; The Institute of Cancer Research, London, UK., Dearnaley D; The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Hall E; The Institute of Cancer Research, London, UK.

مؤلفون مشاركون: CHHiP Trial Management Group

المصدر: European urology oncology [Eur Urol Oncol] 2021 Dec; Vol. 4 (6), pp. 980-992. Date of Electronic Publication: 2021 Sep 03.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms*/radiotherapy , Quality of Life*, Humans ; Male ; Patient Reported Outcome Measures ; Radiation Dose Hypofractionation ; Treatment Outcome

المؤلفون: Connor MJ; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK m.connor@imperial.ac.uk.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK., Shah TT; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Smigielska K; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Day E; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Sukumar J; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Fiorentino F; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Sarwar N; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Gonzalez M; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Falconer A; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Klimowska-Nassar N; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial College Clinical Trials Unit, Imperial College London, London, UK., Evans M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Naismith OF; Radiotherapy Trials Quality Assurance (RTTQA), Royal Marsden NHS Foundation Trust, London, UK., Thippu Jayaprakash K; Department of Oncology, Addenbrooke's Hospital, Cambridge, Cambridgeshire, UK., Price D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Gayadeen S; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Basak D; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Horan G; Department of Oncology, Addenbrooke's Hospital, Cambridge, Cambridgeshire, UK., McGrath J; Department of Urology, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK., Sheehan D; Department of Oncology, Royal Devon and Exeter NHS Foundation Trust, Exeter, Devon, UK., Kumar M; Department of Urology, Arrowe Park Hospital, Wirral University Teaching Hospital NHS Foundation Trust, Wirral, UK., Ibrahim A; Department of Clinical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK., Brock C; Department of Oncology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Pearson RA; Department of Oncology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Anyamene N; Department of Oncology, London North West University Healthcare NHS Trust, Harrow, London, UK., Heath C; Department of Radiotherapy, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Shergill I; Department of Urology, Wrexham Maelor Hospital, Wrexham, UK., Rai B; Department of Urology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Hellawell G; Department of Urology, Northwick Park Hospital, London North West University Healthcare NHS Trust, Harrow, London, UK., McCracken S; Department of Urology, Sunderland Royal Hospital, Sunderland, UK., Khoubehi B; Department of Urology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Mangar S; Department of Oncology, Imperial College Healthcare NHS Trust, London, UK., Khoo V; Department of Oncology, The Royal Marsden NHS Foundation and Institute of Cancer Research, London, UK., Dudderidge T; Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Staffurth JN; Research, Velindre Cancer Centre, Cardiff, UK.; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK., Winkler M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK., Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK.

المصدر: BMJ open [BMJ Open] 2021 Feb 25; Vol. 11 (2), pp. e042953. Date of Electronic Publication: 2021 Feb 25.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists*/therapeutic use , Prostatic Neoplasms*/therapy, Algorithms ; Clinical Trials, Phase II as Topic ; Humans ; Male ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic ; Wales

المؤلفون: Turnham DJ; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Bullock N; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK.; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK., Dass MS; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK., Staffurth JN; Division of Cancer and Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK., Pearson HB; The European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Hadyn Ellis Building, Cardiff CF24 4HQ, UK.

المصدر: Cells [Cells] 2020 Oct 22; Vol. 9 (11). Date of Electronic Publication: 2020 Oct 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor*, PTEN Phosphohydrolase/*genetics , PTEN Phosphohydrolase/*metabolism , Prostatic Neoplasms/*etiology , Prostatic Neoplasms/*metabolism, Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; DNA Damage/drug effects ; Disease Management ; Disease Susceptibility ; Gene Expression Regulation, Neoplastic ; Humans ; Immunomodulation/drug effects ; Male ; Molecular Targeted Therapy ; Prognosis ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/therapy ; Signal Transduction/drug effects ; Treatment Outcome